These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27340029)

  • 1. In vitro and in vivo investigation of the gastrointestinal behavior of simvastatin.
    Geboers S; Stappaerts J; Tack J; Annaert P; Augustijns P
    Int J Pharm; 2016 Aug; 510(1):296-303. PubMed ID: 27340029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
    Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
    Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.
    Prueksaritanont T; Qiu Y; Mu L; Michel K; Brunner J; Richards KM; Lin JH
    Pharm Res; 2005 Jul; 22(7):1101-9. PubMed ID: 16028010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
    Vickers S; Duncan CA; Chen IW; Rosegay A; Duggan DE
    Drug Metab Dispos; 1990; 18(2):138-45. PubMed ID: 1971563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin.
    Ubeaud G; Hagenbach J; Vandenschrieck S; Jung L; Koffel JC
    Life Sci; 1999; 65(13):1403-12. PubMed ID: 10503959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
    Vickers S; Duncan CA; Vyas KP; Kari PH; Arison B; Prakash SR; Ramjit HG; Pitzenberger SM; Stokker G; Duggan DE
    Drug Metab Dispos; 1990; 18(4):476-83. PubMed ID: 1976071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin.
    Hochman JH; Pudvah N; Qiu J; Yamazaki M; Tang C; Lin JH; Prueksaritanont T
    Pharm Res; 2004 Sep; 21(9):1686-91. PubMed ID: 15497697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach.
    Tsamandouras N; Dickinson G; Guo Y; Hall S; Rostami-Hodjegan A; Galetin A; Aarons L
    Pharm Res; 2015 Jun; 32(6):1864-83. PubMed ID: 25446771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro.
    Aura AM; Mattila I; Hyötyläinen T; Gopalacharyulu P; Bounsaythip C; Orešič M; Oksman-Caldentey KM
    Mol Biosyst; 2011 Feb; 7(2):437-46. PubMed ID: 21060933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
    Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
    Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous administration of lactone form of simvastatin stimulates ectopic osteoinduction by rhBMP-2.
    Sugiyama T; Nakagawa T; Sato C; Fujii T; Mine K; Shimizu K; Murata T; Tagawa T
    Oral Dis; 2007 Mar; 13(2):228-33. PubMed ID: 17305627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid.
    Subramanian R; Fang X; Prueksaritanont T
    Drug Metab Dispos; 2002 Mar; 30(3):225-30. PubMed ID: 11854137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic disposition of simvastatin in patients with T-tube drainage.
    Cheng H; Schwartz MS; Vickers S; Gilbert JD; Amin RD; Depuy B; Liu L; Rogers JD; Pond SM; Duncan CA
    Drug Metab Dispos; 1994; 22(1):139-42. PubMed ID: 8149872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats.
    Li Y; Wu Y; Li YJ; Meng L; Ding CY; Dong ZJ
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31035343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral ketoconazole on oral and intravenous pharmacokinetics of simvastatin and its acid in cynomolgus monkeys.
    Ogasawara A; Utoh M; Nii K; Ueda A; Yoshikawa T; Kume T; Fukuzaki K
    Drug Metab Dispos; 2009 Jan; 37(1):122-8. PubMed ID: 18854378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies.
    Stappaerts J; Geboers S; Snoeys J; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Biopharm; 2015 Feb; 90():1-7. PubMed ID: 25592324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells.
    Tulbah AS; Ong HX; Lee WH; Colombo P; Young PM; Traini D
    Pharm Res; 2016 Jan; 33(1):92-101. PubMed ID: 26238046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin decreases steroid production in the H295R cell line and decreases steroids and FSH in female rats.
    Guldvang A; Hansen CH; Weisser JJ; Halling-Sørensen B; Styrishave B
    Reprod Toxicol; 2015 Dec; 58():174-83. PubMed ID: 26476359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population pharmacokinetic-pharmacodynamic model for simvastatin that predicts low-density lipoprotein-cholesterol reduction in patients with primary hyperlipidaemia.
    Kim J; Ahn BJ; Chae HS; Han S; Doh K; Choi J; Jun YK; Lee YW; Yim DS
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):156-63. PubMed ID: 21426490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.